WAT
Waters Corporation
NYSE · Healthcare · Medical - Diagnostics & Research · US
$409.87
−0.89%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 4.6B | 3.2B | 3.0B | 3.0B | 3.0B |
| Cost of Revenue | 2.3B | 1.3B | 1.2B | 1.2B | 1.2B |
| Gross Profit | 2.4B | 1.8B | 1.8B | 1.8B | 1.7B |
| Operating Expenses | |||||
| R&D Expense | 321.7M | 195.2M | 183.0M | 174.9M | 176.2M |
| SG&A Expense | 1.2B | 740.3M | 690.1M | 736.0M | 658.0M |
| General & Admin Expense | 214.2M | — | — | — | — |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | 457.1M | — | 58.7M | 32.6M | 16.2M |
| Total Operating Expenses | 2.0B | 935.5M | 931.8M | 943.5M | 850.4M |
| Cost and Expenses | 4.3B | 2.3B | 2.1B | 2.1B | 2.1B |
| Operating Income (EBIT) | 369.7M | 893.2M | 826.4M | 817.7M | 873.4M |
| Non-Operating | |||||
| Interest Income | 10.7M | 7.4M | 17.4M | 16.6M | 11.0M |
| Interest Expense | 138.3M | 69.5M | 89.7M | 98.9M | 48.8M |
| Net Interest Income | (127.5M) | (62.2M) | (72.3M) | (82.2M) | (37.8M) |
| Other Non-Op Income/Expense | (164.4M) | (138.3M) | (71.5M) | (81.4M) | (35.5M) |
| Non-Operating Income (excl Interest) | 32.1M | 87.6M | (18.2M) | (17.4M) | (13.2M) |
| EBT (Pre-Tax Income) | 205.3M | 754.9M | 754.9M | 736.2M | 837.8M |
| Income Tax Expense | 39.2M | 112.2M | 117.0M | 94.0M | 130.1M |
| Bottom Line | |||||
| Net Income | 166.1M | 642.6M | 637.8M | 642.2M | 707.8M |
| Earnings from Cont. Ops | 166.1M | 642.6M | 637.8M | 642.2M | 707.8M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 166.1M | 642.6M | 637.8M | 642.2M | 707.8M |
| Per Share | |||||
| Basic EPS | $4.02 | $10.80 | $10.75 | $10.87 | $11.80 |
| Diluted EPS | $4.01 | $10.76 | $10.71 | $10.84 | $11.73 |
| Revenue Per Share | $47.29 | $53.19 | $49.86 | $50.04 | $49.54 |
| Shares | |||||
| Basic Shares Outstanding | 98.2M | 59.5M | 59.3M | 59.1M | 60.0M |
| Diluted Shares Outstanding | 98.2M | 59.7M | 59.6M | 59.3M | 60.3M |
| Profitability Metrics | |||||
| EBITDA | 895.8M | 1.0B | 1.0B | 1.0B | 1.0B |
| D&A | 558.2M | 206.2M | 191.8M | 165.9M | 130.4M |
| EBIT | 337.6M | 805.6M | 844.5M | 835.1M | 886.6M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jul 1, 2026